Friday, July 10, 2026

pharma · Advanced Refractory Solid Tumors

CStone Pharmaceuticals

CStone Pharmaceuticals clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Shanghai, CN HQ
2016 Founded
193 Employees
EMA registrant Type
Company details
Status
Public
HQ
Shanghai, CN
Founded
2016
Employees
193
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

CStone Pharmaceuticals projects

1 ClinicalTrials.gov programs sponsored by CStone Pharmaceuticals.

CStone Pharmaceuticals has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CS1001

    Cstone Pharmaceuticals Ireland Limited

    Advanced Refractory Solid Tumors

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does CStone Pharmaceuticals have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.